Kindred Healthcare (NYSE:KND) Upgraded at Zacks Investment Research

Kindred Healthcare (NYSE:KND) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a note issued to investors on Wednesday, January 10th. The firm currently has a $11.00 price objective on the health services provider’s stock. Zacks Investment Research‘s price target suggests a potential upside of 21.55% from the stock’s current price.

According to Zacks, “Kindred Healthcare, Inc., a top-105 private employer in the United States, is a FORTUNE 500 healthcare services company based in Louisville, Kentucky with annual revenues of approximately $6.1 billion(1). Kindred’s continuing operations, through its subsidiaries, had approximately 86,400 employees providing healthcare services in 2,475 locations in 45 states, including 77 long-term acute care hospitals, 19 inpatient rehabilitation hospitals, 16 sub-acute units, 609 Kindred at Home home health, hospice and non-medical home care sites of service, 101 inpatient rehabilitation units (hospital-based) and contract rehabilitation service businesses which served 1,653 non-affiliated sites of service. Ranked as one of Fortune magazine’s Most Admired Healthcare Companies for eight years, Kindred’s mission is to promote healing, provide hope, preserve dignity and produce value for each patient, resident, family member, customer, employee and shareholder they serve. “

Several other analysts also recently commented on the stock. Royal Bank of Canada restated a “sector perform” rating and set a $8.50 price objective (up from $7.50) on shares of Kindred Healthcare in a research report on Thursday, November 9th. ValuEngine upgraded shares of Kindred Healthcare from a “sell” rating to a “hold” rating in a research report on Thursday, November 9th. Deutsche Bank reaffirmed a “hold” rating and set a $9.00 target price (down from $10.00) on shares of Kindred Healthcare in a research note on Monday, September 18th. Stifel Nicolaus raised shares of Kindred Healthcare from a “sell” rating to a “hold” rating and set a $7.00 target price for the company in a research note on Monday, November 20th. Finally, Mizuho set a $9.00 target price on shares of Kindred Healthcare and gave the company a “hold” rating in a research note on Monday, December 18th. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and one has given a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus target price of $9.31.

Shares of Kindred Healthcare (NYSE:KND) remained flat at $$9.05 during mid-day trading on Wednesday. 1,210,000 shares of the company’s stock traded hands, compared to its average volume of 1,560,000. The stock has a market capitalization of $786.74, a P/E ratio of -4.59 and a beta of 1.13. Kindred Healthcare has a 52-week low of $5.50 and a 52-week high of $11.90. The company has a debt-to-equity ratio of 6.22, a quick ratio of 1.53 and a current ratio of 1.55.

Kindred Healthcare (NYSE:KND) last announced its quarterly earnings data on Monday, November 6th. The health services provider reported ($0.11) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.19) by $0.08. The firm had revenue of $1.48 billion for the quarter, compared to the consensus estimate of $1.44 billion. Kindred Healthcare had a negative net margin of 8.06% and a positive return on equity of 2.29%. The company’s revenue was down 5.5% on a year-over-year basis. During the same period last year, the firm earned $0.05 EPS. analysts predict that Kindred Healthcare will post 0.31 earnings per share for the current year.

Institutional investors and hedge funds have recently bought and sold shares of the stock. Janus Henderson Group PLC purchased a new position in Kindred Healthcare during the second quarter valued at $130,000. Highbridge Capital Management LLC purchased a new position in shares of Kindred Healthcare in the 3rd quarter worth $133,000. Amalgamated Bank grew its stake in shares of Kindred Healthcare by 0.9% in the 2nd quarter. Amalgamated Bank now owns 11,518 shares of the health services provider’s stock worth $134,000 after buying an additional 108 shares in the last quarter. Engineers Gate Manager LP purchased a new position in shares of Kindred Healthcare in the 4th quarter worth $153,000. Finally, Crossmark Global Holdings Inc. purchased a new position in shares of Kindred Healthcare in the 3rd quarter worth $208,000. 83.75% of the stock is owned by institutional investors.

COPYRIGHT VIOLATION WARNING: This piece was reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of U.S. and international copyright & trademark laws. The legal version of this piece can be read at https://www.dispatchtribunal.com/2018/02/06/zacks-investment-research-upgrades-kindred-healthcare-knd-to-buy.html.

Kindred Healthcare Company Profile

Kindred Healthcare, Inc, incorporated on March 27, 1998, is a healthcare services company. The Company, through its subsidiaries, operates transitional care (TC) hospitals, a home health, hospice and community care business, inpatient rehabilitation hospitals (IRFs), a contract rehabilitation services business, nursing centers and assisted living facilities across the United States.

Get a free copy of the Zacks research report on Kindred Healthcare (KND)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Kindred Healthcare (NYSE:KND)

Receive News & Ratings for Kindred Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply